Compound 60 has a very high affinity to MDM2 (Ki < 1 nM), strong cellular action, and a very good oral pharmacokinetic profile. Compound 60 is able to attaining entire and extended-Long lasting tumor regression in vivo and it is at this time in phase I clinical trials for most https://ignacyd085tyc8.hyperionwiki.com/user